SPONSOR SHIFTS FROM FALTERING LARGE CRO TO PRC CLINICAL

TEAM MEETS ACCELERATED TIMELINE IN GLOBAL PHASE 2B STUDY

PRC CLINICAL SUPPORTS AUSTRALIAN PHARMA TO RUN US STUDY

FPI BEFORE YEAR-END FOR US-BASED PHASE II STUDY

ENROLLMENT IMPROVED FOR PHASE III CLINICAL STUDY

SUCCESSFUL CRO AUDITS TO RECOVER CRITICAL CLINICAL DATA

SUPPORT OF ISRAELI SPONSOR TO TRANSITION TO THE US MARKET